Illumina, Inc.
(NASDAQ : ILMN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. -0.15%247.721.3%$844.18m
MRNAModerna, Inc. 2.92%69.870.0%$763.28m
NVAXNovavax, Inc. -6.19%108.3696.5%$693.95m
IMMUImmunomedics, Inc. 0.22%85.5311.0%$600.97m
GILDGilead Sciences, Inc. 0.02%65.051.0%$599.14m
REGNRegeneron Pharmaceuticals, Inc. -1.73%555.242.7%$445.10m
BIIBBiogen, Inc. -0.32%274.481.6%$332.97m
VRTXVertex Pharmaceuticals, Inc. -2.24%265.391.9%$329.17m
ILMNIllumina, Inc. -0.85%295.503.5%$313.09m
SRNESorrento Therapeutics, Inc. -0.53%9.431.5%$274.82m
ALXNAlexion Pharmaceuticals, Inc. -0.36%113.722.0%$266.55m
BMRNBioMarin Pharmaceutical, Inc. 1.30%79.384.3%$239.49m
MNTAMomenta Pharmaceuticals, Inc. -0.13%52.263.0%$237.34m
VXRTVaxart, Inc. 3.01%8.220.0%$213.57m
SGENSeattle Genetics, Inc. 3.01%180.946.0%$194.15m

Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.